Highbridge Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Highbridge Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,725	Closed	-$476K	–	2030
2015 Q4	$476K	Buy	+7,725	New	+$544K	0.01%	1009

Highbridge Capital Management's KITE Position: Q1 2016 in Review

Highbridge Capital Management sold out of Kite Pharma, Inc. (KITE) in Q1 2016, closing a stake of 7,725 shares — an estimated $476K sold.

Highbridge Capital Management first reported a position in KITE in Q4 2015 and held it in 1 quarter. The position peaked at $476K in Q4 2015. 171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

Highbridge Capital Management reported no remaining Kite Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
Highbridge Capital Management sold 7,725 Kite Pharma, Inc. shares in Q1 2016, an estimated $476K.
Highbridge Capital Management first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 1 quarter.
Highbridge Capital Management's Kite Pharma, Inc. position peaked at $476K in Q4 2015.
171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on Highbridge Capital Management's 13F filing for Q1 2016, filed 16 May 2016.